Trial intelligence / Profile preview

Bioequivalence of Triomune vs Brand ARVs in HIV

NCT01025830Phase 4Completed

Sponsor
Makerere University
Start
Feb 2006
Primary completion
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of stavudine + lamivudine + nevirapine in human immunodeficiency virus infection (HIV), sponsored by Makerere University. Started Feb 2006; status: completed.

02

Drugs

stavudine + lamivudine + nevirapine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01025830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01025830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call